Compare Stocks → Your $200 account credit is about to expire (From MarketBeat) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:AIBBRNASDAQ:ASCBRNYSE:ASGINASDAQ:HROWL Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAIBBRAIB Acquisition$0.14+21.5%$0.14$0.08▼$0.36N/AN/A5,311 shs100 shsASCBRA SPAC II Acquisition$0.07$0.07$0.01▼$0.99N/AN/A29,246 shsN/AASGIAbrdn Global Infrastructure Income Fund$17.75$17.48$14.96▼$18.55N/AN/A81,847 shs85,274 shsHROWLHarrow Health, Inc. 8.625% Senior Notes due 2026$25.15+0.4%$24.40$22.05▼$25.25N/AN/A6,465 shs4,676 shs7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAIBBRAIB Acquisition0.00%+30.00%-11.20%+29.88%-3.80%ASCBRA SPAC II Acquisition0.00%+0.15%+5.30%-25.00%-30.77%ASGIAbrdn Global Infrastructure Income Fund0.00%+0.62%+3.44%-1.06%+1.72%HROWLHarrow Health, Inc. 8.625% Senior Notes due 2026+0.40%+2.86%+3.67%+5.01%+4.57%SHOCKING Crypto Leak… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAIBBRAIB AcquisitionN/AN/AN/AN/AN/AN/AN/AN/AASCBRA SPAC II AcquisitionN/AN/AN/AN/AN/AN/AN/AN/AASGIAbrdn Global Infrastructure Income FundN/AN/AN/AN/AN/AN/AN/AN/AHROWLHarrow Health, Inc. 8.625% Senior Notes due 2026N/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAIBBRAIB AcquisitionN/AN/AN/AN/AASCBRA SPAC II AcquisitionN/AN/AN/AN/AASGIAbrdn Global Infrastructure Income Fund3.00BuyN/AN/AHROWLHarrow Health, Inc. 8.625% Senior Notes due 2026N/AN/AN/AN/ACurrent Analyst RatingsSales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAIBBRAIB AcquisitionN/AN/AN/AN/AN/AN/AASCBRA SPAC II AcquisitionN/AN/AN/AN/AN/AN/AASGIAbrdn Global Infrastructure Income Fund$10.04MN/AN/AN/AN/AN/AHROWLHarrow Health, Inc. 8.625% Senior Notes due 2026N/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAIBBRAIB AcquisitionN/AN/A0.00∞N/AN/AN/AN/AN/AASCBRA SPAC II AcquisitionN/AN/A0.00∞N/AN/AN/AN/AN/AASGIAbrdn Global Infrastructure Income FundN/AN/A0.00∞N/AN/AN/AN/AN/AHROWLHarrow Health, Inc. 8.625% Senior Notes due 2026N/AN/A0.00∞N/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAIBBRAIB AcquisitionN/AN/AN/AN/AN/AASCBRA SPAC II AcquisitionN/AN/AN/AN/AN/AASGIAbrdn Global Infrastructure Income Fund$1.548.68%+64.26%N/AN/AHROWLHarrow Health, Inc. 8.625% Senior Notes due 2026N/AN/AN/AN/AN/ALatest HROWL, ASCBR, ASGI, and AIBBR DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/11/2024ASGIAbrdn Global Infrastructure Income FundMonthly$0.1510.19%3/20/20243/21/20243/28/20242/9/2024ASGIAbrdn Global Infrastructure Income FundMonthly$0.1510.28%2/21/20242/22/20242/29/20241/10/2024ASGIAbrdn Global Infrastructure Income FundMonthly$0.1610.51%1/23/20241/24/20241/31/20241/11/2024HROWLHarrow Health, Inc. 8.625% Senior Notes due 2026quarterly$0.53918.9%1/11/20241/15/20241/31/2024(Data available from 1/1/2013 forward)OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAIBBRAIB AcquisitionN/AASCBRA SPAC II AcquisitionN/AASGIAbrdn Global Infrastructure Income FundN/AHROWLHarrow Health, Inc. 8.625% Senior Notes due 2026N/AInsider OwnershipCompanyInsider OwnershipAIBBRAIB AcquisitionN/AASCBRA SPAC II AcquisitionN/AASGIAbrdn Global Infrastructure Income FundN/AHROWLHarrow Health, Inc. 8.625% Senior Notes due 2026N/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableAIBBRAIB AcquisitionN/AN/AN/ANot OptionableASCBRA SPAC II AcquisitionN/AN/AN/ANot OptionableASGIAbrdn Global Infrastructure Income FundN/AN/AN/ANot OptionableHROWLHarrow Health, Inc. 8.625% Senior Notes due 202622N/AN/ANot OptionableHROWL, ASCBR, ASGI, and AIBBR HeadlinesSourceHeadlineHarrow, Inc. - 8.625% senior notes due 2026 Stock (NASDAQ:HROWL) Dividends: History, Yield and Datesbenzinga.com - February 22 at 1:50 PMHarrow: Hedge Downside Risk With The 11.5% Yielding Baby Bondsseekingalpha.com - February 5 at 7:44 AMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsAIB AcquisitionNASDAQ:AIBBRAIB Acquisition Corporation does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses in the fintech industries. The company was incorporated in 2021 and is based in New York, New York.A SPAC II AcquisitionNASDAQ:ASCBRA SPAC II Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to pursue prospective targets that are in the industries that apply technologies, such as Proptech and Fintech in North America, Europe, and Asia. The company was incorporated in 2021 and is based in Singapore. A SPAC II Acquisition Corporation operates as a subsidiary of A SPAC II (Holdings) Corp.Abrdn Global Infrastructure Income FundNYSE:ASGIAberdeen Standard Global Infrastructure Income Fund seeks to provide a high level of total return with an emphasis on current income by investing in assets that provide necessary services to society. The Fund seeks to achieve its investment objective by investing in a portfolio of income-producing public and private infrastructure equity investments from around the world.Harrow Health, Inc. 8.625% Senior Notes due 2026NASDAQ:HROWLharrow health, inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the united states. the company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. it also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. its products portfolio includes topical eye drop drug candidates, including surf-100 and surf-200; surf-300, an oral capsule for treating patients suffering from ocular surface diseases, and ded signs and symptoms; klarity drops to protect and rehabilitate the ocular surface pathology for patients with ded; melt-100, a drug that is administered sublingually for conscious sedation during cataract surgery; may-66 that is used for the treatment of symptoms associated with peyronie's diseas Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.